Evidence map›Paper›PMID 35323477›Full record

ArticleMarine drugs2022

Anti-Osteoclastogenic and Antibacterial Effects of Chlorinated Polyketides from the Beibu Gulf Coral-Derived Fungus

Yanting Zhang, Zhichao Li, Bingyao Huang, Kai Liu, Shuai Peng, Xinming Liu, Chenghai Gao, Yonghong Liu, Yanhui Tan, Xiaowei Luo

Open access · goldAbstract read
In one paragraph

Article in Marine drugs, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Metabolic bone disorders and the promise of marine osteoactive compounds.Cellular and molecular life sciences : CMLS · 2023
    Review
  12. MarineMarine drugs · 2023
    Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Yanting ZhangInstitute of Marine Drugs, Guangxi University of Chinese Medicine, Nanning 530200, China.
Zhichao LiState Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, School of Chemistry and Pharmaceutical Sciences, Guangxi Normal University, Guilin 541004, China.
Bingyao HuangInstitute of Marine Drugs, Guangxi University of Chinese Medicine, Nanning 530200, China.
Kai LiuInstitute of Marine Drugs, Guangxi University of Chinese Medicine, Nanning 530200, China.
Shuai PengInstitute of Marine Drugs, Guangxi University of Chinese Medicine, Nanning 530200, China.
Xinming LiuInstitute of Marine Drugs, Guangxi University of Chinese Medicine, Nanning 530200, China.
Chenghai GaoInstitute of Marine Drugs, Guangxi University of Chinese Medicine, Nanning 530200, China.
Yonghong LiuInstitute of Marine Drugs, Guangxi University of Chinese Medicine, Nanning 530200, China.ORCID 0000-0001-8327-3108
Yanhui TanState Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, School of Chemistry and Pharmaceutical Sciences, Guangxi Normal University, Guilin 541004, China.
Xiaowei LuoInstitute of Marine Drugs, Guangxi University of Chinese Medicine, Nanning 530200, China.ORCID 0000-0002-2114-1609
Guangxi University · CNGuangxi Normal University · CN

Funding

Guangxi Young and Middle-aged University Teachers' Scientific Research Ability Enhancement Project 2021KY0315National Natural Science Foundation of China U20A20101, 82104496Natural Science Foundation of Guangxi 2021GXNSFDA075010, 2020GXNSFGA297002the Scientific Research Foundation of Guangxi University of Chinese Medicine 2018006, 2018ZD005, 2019BS021, 2020QN025the Special Fund for Bagui Scholars of Guangxi Yonghong Liuthe Special Fund for Hundred Talents Program for Universities in Guangxi Kai Liuthe Specific Research Project of Guangxi for Research Bases and Talents AD19110013
6 · The paper itself

Abstract

One new depsidone derivative, aspergillusidone H (

Indexed as

Anti-Bacterial AgentsBiological ProductsPolyketidesAnimalsAnthozoaAspergillusBacteriaCells, CulturedLipopolysaccharidesMacrophagesMiceMolecular StructureNF-kappa BOceans and SeasOsteogenesisRANK LigandAnti-Bacterial AgentsBiological ProductsLipopolysaccharidesNF-kappa BPolyketidesRANK LigandantibacterialAspergillus unguisdepsidesdepsidonesmarine fungiosteoclast differentiation

Identifiers

PMID35323477
PMCPMC8956104
OpenAlexW4214653315

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.